The Regional Group on Specialist Medicines has recommended that medicines suitable for shared care arrangements be designated to an advisory list, the Amber List. The Group has further recommended that prescribing responsibility may be transferred to primary care when agreed shared care arrangements have been established. Such shared care arrangements will make recommendations on the respective clinical responsibilities of both parties.
Currently, in collaboration with the Interface Pharmacist Network Specialist Medicines, healthcare professionals working within the HSC are facilitating the development of regional guidelines for specific medicines or therapeutic group of medicines. Following endorsement of the guidance by the Regional Group, implementation should be brought forward at local level. A repository of regional guidelines is held on this website. Further Regional Guidelines will be posted on this site as they become available.
Every care is taken to ensure that the advice contained in these guidelines is believed to represent best practice at the time of going to press. It is policy to revise the guidelines as new developments occur, but it may not be possible to do this at the time of such changes and the guidelines should always be used with due regard to current acceptable practice. Comments are invited to assist the review process. All correspondence regarding the guidelines should be sent to your local Interface Pharmacist for Specialist Medicines.
